Benzonatate
Generic Formulation: BENZONATATE
Regulatory Registrant: REMEDYREPACK INC.
Related NDC Products
| NDC Code | Dosage Form | Route | Category |
|---|---|---|---|
| 71335-1553 | CAPSULE | ORAL | ANDA |
| 63187-606 | CAPSULE | ORAL | ANDA |
| 71335-1880 | CAPSULE | ORAL | ANDA |
| 62135-440 | CAPSULE | ORAL | ANDA |
| 70518-4497 | CAPSULE | ORAL | ANDA |
Indications & Usage
INDICATIONS AND USAGE Benzonatate Capsule is indicated for the symptomatic relief of cough.
Dosage & Administration
DOSAGE AND ADMINISTRATION Adults and Children over 10 years of age Usual dose is one 100 mg or 200 mg capsule three times a day as needed for cough. If necessary to control cough, up to 600 mg daily in three divided doses may be given. Benzonatate Capsules should be swallowed whole. Benzonatate Capsules are not to be broken, chewed, dissolved, cut or crushed.
Side Effects
ADVERSE REACTIONS Potential Adverse Reactions to Benzonatate Capsules may include: Hypersensitivity reactions including bronchospasm, laryngospasm,cardiovascular collapse possibly related to local anesthesia from chewing or sucking the capsule. CNS: sedation; headache; dizziness; mental confusion; visual hallucinations. GI: constipation; nausea; GI upset. Dermatologic: pruritus; skin eruptions. Other: nasal congestion; sensation of burning in the eyes; vague "chilly" sensation; numbness of the chest; hypersensitivity. Deliberate or accidental overdose has resulted in death, particularly in children.